Evidence-Based Medicine Guidelines
Hemiarginate in acute porphyria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hemiarginate in Acute Porphyria." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria.
Hemiarginate in acute porphyria. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria. Accessed April 27, 2025.
Hemiarginate in acute porphyria. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria
Hemiarginate in Acute Porphyria [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hemiarginate in acute porphyria
ID - 455075
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455075/all/Hemiarginate_in_acute_porphyria
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
